IMCD N.V., a leading distributor, formulator, and solutions provider of speciality chemicals and ingredients, has recently signed an agreement to acquire 100% of the shares of the speciality distribution company, Euro Chemo-Pharma Sdn Bhd and its wholly owned subsidiary, Biofresh Green Sdn Bhd.
Euro Chemo-Pharma was formed in Malaysia in 1975, offering a wide range of products from food to pharmaceutical and personal care applications.
Headquartered in Penang, with offices and warehouses also in Kuala Lumpur and Johor, Euro Chemo-Pharma ensures the full coverage of the Malaysian market. The company also represents leading global suppliers providing its customers with an extensive portfolio backed by in-depth formulation expertise. With an annual revenue of RM270 million (US$58.8 million) in the financial year ended June 2022, Euro Chemo-Pharma acquisition will add 124 more employees and an application laboratory in Penang for IMCD.
Euro Chemo-Pharma’s subsidiary, Biofresh, also includes blending, mixing, and compounding of food and flavour ingredients and holds the Halal certification.
Andreas Igerl, President at IMCD APAC said, “Euro Chemo-Pharma’s strategic positioning is fully aligned with IMCD, providing us the complementary portfolio to accelerate growth in the Malaysian market. In addition, we aim to leverage the suppliers’ synergies we gain from them to develop further our life science business in the Asia Pacific markets.”
Jeryl Tan, Executive Director at Euro Chemo-Pharma said, “We have managed to grow the company to be the largest and most efficient speciality ingredients distributor in Malaysia…. we believe that IMCD would be our best partner in the journey to drive growth and provide an exciting new home for our people.”
For more information, click on:
IMCD Asia Pte Ltd
